Latest Insider Transactions at Bluejay Diagnostics, Inc. (BJDX)
This section provides a real-time view of insider transactions for Bluejay Diagnostics, Inc. (BJDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bluejay Diagnostics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bluejay Diagnostics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Indranil Dey President and CEO |
BUY
Open market or private purchase
|
Direct |
500
+1.72%
|
$1,500
$3.27 P/Share
|
|
Dec 13
2023
|
Svetlana Dey Director |
BUY
Open market or private purchase
|
Direct |
500
+25.0%
|
$1,500
$3.07 P/Share
|
|
Mar 28
2023
|
Indranil Dey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+0.3%
|
$0
$0.44 P/Share
|
|
Mar 27
2023
|
Indranil Dey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+1.41%
|
$0
$0.44 P/Share
|
|
Mar 24
2023
|
Svetlana Dey Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+17.39%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Gary G Gemignani Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+50.0%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Svetlana Dey Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+42.31%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Donald R Chase Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+3.35%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Kenneth R Fisher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,316
-25.78%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Kenneth R Fisher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,500
+42.45%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Indranil Dey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,612
-9.17%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Indranil Dey President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
159,090
+20.79%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Douglas Clark Wurth Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+1.17%
|
$0
$0.44 P/Share
|
|
Feb 01
2023
|
Fred S Zeidman Director |
BUY
Grant, award, or other acquisition
|
Direct |
27,500
+50.0%
|
$0
$0.44 P/Share
|
|
Aug 26
2022
|
Kenneth R Fisher Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+33.33%
|
$20,000
$1.03 P/Share
|
|
Apr 25
2022
|
Kenneth R Fisher Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$0
$0.99 P/Share
|
|
Mar 17
2022
|
Svetlana Dey Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.18 P/Share
|
|
Mar 17
2022
|
Gordon Winston Kinder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+11.9%
|
$2,500
$1.16 P/Share
|
|
Mar 17
2022
|
Douglas Clark Wurth Director |
BUY
Open market or private purchase
|
Direct |
40,000
+1.72%
|
$40,000
$1.18 P/Share
|
|
Mar 16
2022
|
Douglas Clark Wurth Director |
BUY
Open market or private purchase
|
Direct |
60,000
+2.6%
|
$60,000
$1.09 P/Share
|
|
Mar 16
2022
|
Gordon Winston Kinder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+23.81%
|
$5,000
$1.02 P/Share
|
|
Mar 15
2022
|
Gordon Winston Kinder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
500
+4.35%
|
$0
$0.91 P/Share
|
|
Mar 14
2022
|
Gordon Winston Kinder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,500
+50.0%
|
$0
$0.95 P/Share
|